相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response
A. Hajiran et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations
Daria Miroshnychenko et al.
NATURE ECOLOGY & EVOLUTION (2021)
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
David A. Braun et al.
CANCER CELL (2021)
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy
Saif Zaman et al.
EUROPEAN UROLOGY FOCUS (2021)
A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma
Dhruv N. Patel et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2021)
Estimating and comparing biodiversity with a single universal metric
Roberto Cazzolla Gatti et al.
ECOLOGICAL MODELLING (2020)
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A. Braun et al.
NATURE MEDICINE (2020)
The immunology of renal cell carcinoma
C. Marcela Diaz-Montero et al.
NATURE REVIEWS NEPHROLOGY (2020)
Combination Therapy as First-Line Treatment in Metastatic Renal-Cell Carcinoma
Bernard Escudier
NEW ENGLAND JOURNAL OF MEDICINE (2019)
T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates
Andrea M. Roca et al.
HUMAN IMMUNOLOGY (2019)
Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database
Shengjie Guo et al.
CANCER MEDICINE (2019)
T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer
Boris I. Chobrutskiy et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Leveraging Single-Cell RNA Sequencing Experiments to Model Intratumor Heterogeneity
Meghan C. Ferrall-Fairbanks et al.
JCO CLINICAL CANCER INFORMATICS (2019)
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Kathleen A. Cronin et al.
CANCER (2018)
T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns
Blake M. Callahan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao et al.
SCIENCE (2018)
The changing landscape of naive T cell receptor repertoire With human aging
Evgeny S. Egorov et al.
FRONTIERS IN IMMUNOLOGY (2018)
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade
Boris I. Chobrutskiy et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Saman Maleki Vareki
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Overview of methodologies for T-cell receptor repertoire analysis
Elisa Rosati et al.
BMC BIOTECHNOLOGY (2017)
Dynamics of Individual T Cell Repertoires: From Cord Blood to Centenarians
Olga V. Britanova et al.
JOURNAL OF IMMUNOLOGY (2016)
Robust estimates of overall immune-repertoire diversity from high-throughput measurements on samples
Joseph Kaplinsky et al.
NATURE COMMUNICATIONS (2016)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
Andriy Marusyk et al.
NATURE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
Vanessa Almendro et al.
CELL REPORTS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Estimating the diversity, completeness, and cross-reactivity of the T cell repertoire
Veronika I. Zarnitsyna et al.
FRONTIERS IN IMMUNOLOGY (2013)
Racial differences in B cell receptor signaling pathway activation
Diane M. Longo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
A consistent terminology for quantifying species diversity? Yes, it does exist
Hanna Tuomisto
OECOLOGIA (2010)
Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire
Jacob Glanville et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Partitioning diversity into independent alpha and beta components
Lou Jost
ECOLOGY (2007)
The many important facets of T-cell repertoire diversity
J Nikolich-Zugich et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Systemic therapy for renal cell carcinoma
RJ Motzer et al.
JOURNAL OF UROLOGY (2000)
分享论文
